Suppr超能文献

门诊手术中单剂量静脉注射地塞米松的术前应用:效益与风险。

Preoperative single-dose intravenous dexamethasone during ambulatory surgery: update around the benefit versus risk.

出版信息

Curr Opin Anaesthesiol. 2010 Dec;23(6):682-6. doi: 10.1097/ACO.0b013e32833ff302.

Abstract

PURPOSE OF REVIEW

Pain, emesis, and fatigue are not uncommon symptoms after ambulatory surgery having impact on patients' satisfaction with quality of care. Multimodal management of postoperative pain and nausea and vomiting has become standard of care.

RECENT FINDINGS

There is a growing body of evidence for the beneficial effects from preoperative single-dose intravenous (i.v.) glucocorticoids for reducing pain, emesis, and fatigue, thereby improving the recovery process and patient satisfaction. Side-effects are infrequently reported.

SUMMARY

The benefits versus risk associated to single preoperative i.v. dose of dexamethasone seem positive based on current evidence facilitating the recovery reducing pain and postoperative nausea and vomiting.

摘要

目的综述

疼痛、恶心和疲劳在门诊手术后并不少见,会影响患者对护理质量的满意度。多模式管理术后疼痛、恶心和呕吐已成为常规治疗。

最近发现

越来越多的证据表明,术前单次静脉(i.v.)给予糖皮质激素可减轻疼痛、恶心和疲劳,从而改善恢复过程和患者满意度。副作用很少见。

总结

基于目前的证据,单次术前静脉给予地塞米松的益处大于风险,有利于促进恢复、减轻疼痛和术后恶心呕吐。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验